UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Future nurses' cultural competencies: what are their learning experiences during exchange and studies abroad? A systematic literature review

Journal of nursing management, 2011-07, Vol.19 (5), p.673-682

KOKKO, RAIJA

2011

Volltextzugriff (PDF)

Follow-up cost of breast cancer patients with localized disease after primary treatment : a randomized trial

Breast cancer research and treatment, 2005-10, Vol.93 (3), p.255-260

2005

Volltextzugriff (PDF)

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

Breast cancer research and treatment, 2001-05, Vol.67 (2), p.117-123

2001

Volltextzugriff (PDF)

Very high quantitative tumor HER2 content and outcome in early breast cancer

Annals of oncology, 2011-09, Vol.22 (9), p.2007-2013

2011

Volltextzugriff (PDF)

Ca 15-3 in the follow-up of localised breast cancer: a prospective study

European journal of cancer (1990), 2002-06, Vol.38 (9), p.1189-1193

2002

Volltextzugriff (PDF)

Frost quakes in wetlands in northern Finland during extreme winter weather conditions and related hazard to urban infrastructure

The cryosphere, 2024-05, Vol.18 (5), p.2223-2238

2024

Volltextzugriff (PDF)

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

Annals of oncology, 2010-05, Vol.21 (5), p.968-973

2010

Volltextzugriff (PDF)

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

The New England journal of medicine, 2006-02, Vol.354 (8), p.809-820

2006

Volltextzugriff (PDF)

Role of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial

Breast cancer research and treatment, 2003-09, Vol.81 (1), p.33-39

2003

Volltextzugriff (PDF)

Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

Annals of oncology, 2009-03, Vol.20 (3), p.595-596

2009

Volltextzugriff (PDF)

S24 Update of the FINHER trial based on 5 years of follow-up

Breast (Edinburgh), 2009, Vol.18, p.S10-S10

2009

Volltextzugriff (PDF)

The Visibility of Cancer on Previous Mammograms in Retrospective Review

Clinical radiology, 2001-01, Vol.56 (1), p.40-43

2001

Volltextzugriff (PDF)

Validity of radiological examinations of patients with breast cancer in different age groups in a population based study

Breast (Edinburgh), 2001-02, Vol.10 (1), p.78-81

2001

Volltextzugriff (PDF)

Abstract PD01-02: Integration of Capecitabine into Anthracycline-and Taxane-Based Adjuvant Therapy for Triple-Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.PD01-02-PD01-02

2010

Volltextzugriff (PDF)

Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.S4-S4-1

2010

Volltextzugriff (PDF)

Integration of capecitabine (X) into adjuvant therapy comprising docetaxel (T) followed by 5-FU, epirubicin, and cyclophosphamide (CEF): Efficacy in patients with triple-negative breast cancer (BC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.531-531

2010

Volltextzugriff (PDF)

Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) → 5-FU + epirubicin + cyclophosphamide (CEF) adjuvant therapy for high-risk early breast cancer (BC): interim analysis of the FinXX-trial

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.82

2009

Volltextzugriff (PDF)

Docetaxel 100 versus 80 mg/m[sup]2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

Annals of oncology, 2009-03, Vol.20 (3), p.595

2009

Volltextzugriff (PDF)

Single-agent docetacel (D) versus docetaxel alternating with single-agent gemcitabine (G) as treatments of patients (pts) with advanced breast cancer (ABC): Final analysis of a randomized trial

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1035-1035

2008

Volltextzugriff (PDF)

The FinXX trial: Safety results in 600 patients (pts) randomized to either docetaxel (T) followed by cyclophosphamide (C) + epirubicin (E) + 5-FU (F) (CEF) or T + capecitabine (X) followed by CEX as adjuvant therapy for early breast cancer (BC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.11035-11035

2007

Volltextzugriff (PDF)

Paclitaxel-ifosfamide for anthracycline-resistant advanced breast cancer

International journal of clinical pharmacology research, 2002, Vol.22 (2), p.47

2002

Volltextzugriff (PDF)

Ca 15-3 in the follow-up of localised breast cancer

European journal of cancer (1990), 2002-06, Vol.38 (9), p.1189-1193

2002

Volltextzugriff (PDF)

Phase III, randomized study of docetaxel (T) + capecitabine (X) (TX) followed by cyclophosphamide (C) + epirubicin (E) + X (CEX) vs. T followed by C + E + fluorouracil (F) (CEF) as adjuvant treatment for patients (pts) with early breast cancer (BC): An interim safety analysis

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.719-719

2005

Volltextzugriff (PDF)

1 – 25 von 416

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(382)
Mit Volltextzugriff
(366)

Publikationsform

Sprache

Englisch
(412)
Russisch
(2)
Finnisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(289)
Life Sciences & Biomedicine
(232)
Humans
(138)
Female
(123)
Biological And Medical Sciences
(105)
Male
(91)
Animals
(76)
Medical Sciences
(61)
Middle Aged
(54)
Adult
(51)
Fundamental And Applied Biological Sciences. Psychology
(47)
Physical Sciences
(45)
Environmental Sciences & Ecology
(32)
Genetics & Heredity
(32)
Aged
(31)
Physics
(31)
Ecology
(30)
Technology
(30)
Mutation
(27)
Evolutionary Biology
(26)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pattern and dynamics of metastatic sites during course of metastatic colorectal cancer (mCRC) trajectory in 1086 Finnish patients in the nationwide prospective RAXO study

Future nurses' cultural competencies: what are their learning experiences during exchange and studies abroad? A systematic literature review

Follow-up cost of breast cancer patients with localized disease after primary treatment : a randomized trial

The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography

Very high quantitative tumor HER2 content and outcome in early breast cancer

Ca 15-3 in the follow-up of localised breast cancer: a prospective study

Frost quakes in wetlands in northern Finland during extreme winter weather conditions and related hazard to urban infrastructure

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Role of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial

Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

S24 Update of the FINHER trial based on 5 years of follow-up

PD-028Pattern and dynamics of metastatic sites during course of metastatic colorectal cancer (mCRC) trajectory in 1086 Finnish patients in the nationwide prospective RAXO study

The Visibility of Cancer on Previous Mammograms in Retrospective Review

Validity of radiological examinations of patients with breast cancer in different age groups in a population based study

Abstract PD01-02: Integration of Capecitabine into Anthracycline-and Taxane-Based Adjuvant Therapy for Triple-Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study

Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer

Integration of capecitabine (X) into adjuvant therapy comprising docetaxel (T) followed by 5-FU, epirubicin, and cyclophosphamide (CEF): Efficacy in patients with triple-negative breast cancer (BC)

Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) → 5-FU + epirubicin + cyclophosphamide (CEF) adjuvant therapy for high-risk early breast cancer (BC): interim analysis of the FinXX-trial

Docetaxel 100 versus 80 mg/m[sup]2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

Single-agent docetacel (D) versus docetaxel alternating with single-agent gemcitabine (G) as treatments of patients (pts) with advanced breast cancer (ABC): Final analysis of a randomized trial

The FinXX trial: Safety results in 600 patients (pts) randomized to either docetaxel (T) followed by cyclophosphamide (C) + epirubicin (E) + 5-FU (F) (CEF) or T + capecitabine (X) followed by CEX as adjuvant therapy for early breast cancer (BC)

Paclitaxel-ifosfamide for anthracycline-resistant advanced breast cancer

Ca 15-3 in the follow-up of localised breast cancer

Phase III, randomized study of docetaxel (T) + capecitabine (X) (TX) followed by cyclophosphamide (C) + epirubicin (E) + X (CEX) vs. T followed by C + E + fluorouracil (F) (CEF) as adjuvant treatment for patients (pts) with early breast cancer (BC): An interim safety analysis

Suchergebnisse filtern